Literature DB >> 19735293

Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.

Naroa Ibarretxe-Bilbao1, Carme Junque, Eduardo Tolosa, Maria-Jose Marti, Francesc Valldeoriola, Nuria Bargallo, Mojtaba Zarei.   

Abstract

Decision-making and recognition of emotions are often impaired in patients with Parkinson's disease (PD). The orbitofrontal cortex (OFC) and the amygdala are critical structures subserving these functions. This study was designed to test whether there are any structural changes in these areas that might explain the impairment of decision-making and recognition of facial emotions in early PD. We used the Iowa Gambling Task (IGT) and the Ekman 60 faces test which are sensitive to the integrity of OFC and amygdala dysfunctions in 24 early PD patients and 24 controls. High-resolution structural magnetic resonance images (MRI) were also obtained. Group analysis using voxel-based morphometry (VBM) showed significant and corrected (P < 0.05 FEW-small volume correction) gray matter (GM) loss in the right amygdala and bilaterally in the OFC in PD patients. Volumetric analyses were also performed but did not yield significant differences between groups. Left lateral GM volume in OFC showed a slight correlation with the IGT, and bilateral OFC GM was strongly correlated with Ekman test performance in PD patients. We conclude that: (i) impairment in decision-making and recognition of facial emotions occurs at the early stages of PD, (ii) these neuropsychological deficits are accompanied by degeneration of OFC and amygdala, and (iii) bilateral OFC reductions are associated with impaired recognition of emotions, and GM volume loss in left lateral OFC is related to decision-making impairment in PD.

Entities:  

Mesh:

Year:  2009        PMID: 19735293     DOI: 10.1111/j.1460-9568.2009.06892.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  52 in total

Review 1.  Personality and social cognition in neurodegenerative disease.

Authors:  Tal Shany-Ur; Katherine P Rankin
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

Review 2.  Decision-making cognition in neurodegenerative diseases.

Authors:  Ezequiel Gleichgerrcht; Agustín Ibáñez; María Roca; Teresa Torralva; Facundo Manes
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

Review 3.  Impulsivity and Parkinson's disease: more than just disinhibition.

Authors:  Francesca Antonelli; Nicola Ray; Antonio P Strafella
Journal:  J Neurol Sci       Date:  2011-06-17       Impact factor: 3.181

Review 4.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

5.  Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Authors:  Angela M Lee; Erik B Oleson; Leontien Diergaarde; Joseph F Cheer; Tommy Pattij
Journal:  Basal Ganglia       Date:  2012-07-28

Review 6.  Trends and issues in characterizing early cognitive changes in Parkinson's disease.

Authors:  Daniel O Claassen; Scott A Wylie
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 7.  What can biomarkers tell us about cognition in Parkinson's disease?

Authors:  Brit Mollenhauer; Lynn Rochester; Alice Chen-Plotkin; David Brooks
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

8.  Perception of Communicative and Non-communicative Motion-Defined Gestures in Parkinson's Disease.

Authors:  Abhishek Jaywant; Victor Wasserman; Maaria Kemppainen; Sandy Neargarder; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2016-04-08       Impact factor: 2.892

Review 9.  Reward processing in neurodegenerative disease.

Authors:  David C Perry; Joel H Kramer
Journal:  Neurocase       Date:  2014-01-13       Impact factor: 0.881

10.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.